Patient Preferences for Self-Administered Subcutaneous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy.

Kuatov B, Cashmore S-J, Hahn N, Braverman J, Undreiner L, Weng S, Gibbons B

Neurol Ther. 2026 Oct 30. PMID: 42961630. Abstract